CA7026

N/A

Report date: 2025/11/10 10:12:05

Base Information

Drug NameCA7026
Drug Alias NameCA7026CA-7026
ClassificationOther
Mechanisms of ActionJanus kinase inhibitors
TargetsJanus kinase
Therapy Area/IndicationsPsoriasisInflammatory Bowel DiseasesArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Chunan Biopharmaceutical Technology Co., Ltd.
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Chunan Biopharmaceutical Technology Co., Ltd.
Inactive CompaniesN/A
Active IndicationsPsoriasisInflammatory Bowel DiseasesArthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A